Stopping the circadian pacemaker with inhibitors of protein synthesis.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 1438290.
- Also identified by PMC identifier 50442.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The requirement for protein synthesis in the mechanism of a circadian pacemaker was investigated by using inhibitors of protein synthesis. Continuous treatment of the ocular circadian pacemaker of the mollusc Bulla gouldiana with anisomycin or cycloheximide substantially lengthened (up to 39 and 52 hr, respectively) the free-running period of the rhythm. To determine whether high concentrations of inhibitor could stop the pacemaker, long pulse treatments of various durations (up to 44 hr) were applied and the subsequent phase of the rhythm was assayed. The observed phases of the rhythm after the treatments were a function of the time of the end of the treatment pulse, but only for treatments which spanned subjective dawn. The results provide evidence that protein synthesis is required in a phase-dependent manner for motion of the circadian pacemaker to continue.
Medical subject headings
- Anisomycin
- Biological Clocks
- Circadian Rhythm
- Cycloheximide
- Mollusca
- Optic Nerve
- Protein Synthesis Inhibitors